Frequently Asked Questions

Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.

1. Ophtalmology

Ophthalmologists treat a wide range of conditions including cataracts, glaucoma, macular degeneration, diabetic retinopathy, and refractive errors like nearsightedness and farsightedness.

Adults should have a comprehensive eye exam at least once every two years, or more frequently if advised by your eye doctor based on your age, health, and risk factors.

Signs include blurred vision, difficulty seeing objects up close or far away, frequent headaches, eye strain, and squinting.

An eye exam involves tests for visual acuity, assessment of eye muscle function, pupil response, and examination of the retina and optic nerve. It may include dilation to allow a better view of the back of the eye.

Regular eye exams, maintaining a healthy diet rich in antioxidants, protecting your eyes from UV rays with sunglasses, and avoiding smoking can help reduce the risk of eye diseases.

2. DENGUE NS1 ANTIGEN

Dengue fever is a mosquito-borne viral infection causing flu-like symptoms, and in severe cases, it can lead to dengue hemorrhagic fever or dengue shock syndrome.

Anyone experiencing symptoms of dengue fever, particularly within the first few days of illness, should consider this test for early diagnosis.

Yes, the Dengue NS1 Antigen Test is highly accurate in detecting early dengue infection, especially within the first five days of symptom onset.

The test involves a blood draw, which is then analyzed in a laboratory to detect the NS1 antigen.

A positive result indicates a dengue infection. Your healthcare provider will discuss treatment options and may recommend further testing or monitoring.

3. Who is a candidate for bladder tumor resection?

Candidates include individuals diagnosed with bladder tumors or cancer, including those with benign or malignant growths.